Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Calcium Channel Blocker Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1752086A reveals a mild, one-pot synthesis for Azelnidipine intermediates, offering high purity and cost reduction in calcium channel blocker manufacturing.
Patent CN101508672B details a resin-catalyzed esterification method for 1,4-dihydropyridines, offering high purity and scalable production for cardiovascular drug manufacturers.